Bringing Best Evidence to Clinicians 2022

Bringing Best Evidence to Clinicians 2022

We are excited to bring the UBC Therapeutics Initiative annual educational event/half-day conference to you in virtual format again this year.

Join the discussions about new research on: back pain, hypertension, type 2 diabetes, and optimal prescribing presented by new and veteran faculty members at the Therapeutics Initiative, featuring presentations by Dr. Anshula Ambasta, Dr. Wade Thompson, Dr. Rita McCracken, and Dr. Aaron Tejani.

Participate in an innovative session to design new communication pathways among healthcare providers.

WHEN: Saturday, October 15, 2022. 8:00 am to 1:00 pm PDT [convert to your local time]

WHERE: virtual/online option, see full description below

ACCREDITATION: 3.5  Mainpro+, MOC Section 1

INTENDED AUDIENCE: Family Medicine, Nurse Practitioners, Pharmacy/Therapeutics, Registered Nurses, Rural Medicine, Specialty Medicine, Other.

COST: varies. See full description below.

Can’t join us live on Oct 15?
All lectures will be recorded and available to watch on-demand for up to 3 months after the event.

Organized by UBC Faculty of Medicine Continuing Professional Development.


(Pacific Time)
8:00 Registration opens    
8:30 Welcome remarks    Dr. Rita McCracken
Dr. Aaron M. Tejani 
8:45 Making diabetes care fit for older persons
In this presentation, Dr. Thompson will review considerations for managing diabetes in older persons (particularly frail, older persons with multi-morbidity and/or functional limitations), including A1c targets, and evidence on benefits and harms of specific medications. He will discuss how to individualize therapy among older persons according to their individual health context. Finally, he will review when and how to consider deintensifying diabetes management for individual patients.
  Dr. Wade Thompson
 9:10 Mechanical back pain in primary care – which drugs “work”? 
A review of mechanical back pain for primary care clinicians, including pearls for differentiating it from other causes of pain, a review of populations most affected and the natural history of the condition. We will also review what is known about expected harms and benefits of pharmaceutical therapies.
  Dr. Rita McCracken
9:35 Break 
10:00 Concurrent sessions
Stream A  How do we facilitate or improve collaborative medication reviews between pharmacists and prescribers? (group discussion)
** More details coming soon
 Facilitators TBC
Stream B Practical tips to optimize collaborative medication reviews between pharmacists and prescribers
**More details coming soon
 Facilitators TBC
11:00 Navigating complicated issues in hypertension management
Participants will be given tips on how to move new and existing hypertension patients towards the most evidence-informed treatment and targets. Topics covered are listed below:

  • Understand the diagnostic approach to hypertension in adults and identifying drug-related causes for hypertension (e.g. possible prescribing cascades)
  • Describe ways to move patients toward evidence-informed management (e.g. deintensification, changing drug classes)
  • Describe how to individualize the BP target goal for different types of patients (e.g. elderly, non-elderly, DM, CKD)
Dr. Anshula Ambasta
11:30 Optimizing drug therapy with all the tools in the toolbox
Using pharmacology, kinetics (e.g. half-life), and drug effect estimates, participants will be given practical tips to help optimize drug therapy for individuals. Several examples will be used to explain when fast or slow dose titration might be required and when slow or fast tapering is safest.
Dr. Aaron M. Tejani
11:55 Closing Remarks 
12:15 Lunch and networking
(In-person attendees only)
13:00 Conference Ends


VIRTUAL By Sep 6 After Sep 6
Physician/Nurse Practitioner/Pharmacist $149 $164
Allied Health $125 $140
Resident/Student $25 $35
  • All prices are in Canadian dollars. 5% GST applies to all registration fees.
  • Registration includes: access to the plenary sessions, concurrent sessions, online syllabus, and access to the post-event recordings
  • Cancellations: 
    • No refunds or transfers, unless you cancel in writing to by Mon Oct 10, 2022. A $25.00 processing fee will apply. We suggest you not cancel your registration if you cannot attend live, as you can still access the recordings and watch them on-demand. 


photo of Dr. Anshula AmbastaAnshula Ambasta, MD, MPH, FRCPC. 
Dr. Ambasta is a general internist with a research focus on healthcare quality and patient safety. Dr. Ambasta pursued a Masters in Public Health at the Harvard T.H. Chan School of Public Health with a focus on Clinical Effectiveness. She is an Assistant Professor in the Department of Anesthesiology, Pharmacology and Therapeutics at the University of British Columbia. Her overall research program focuses on reduction of low-value services in health systems. She is a member of the Choosing Wisely Canada national expert group dedicated to reducing unnecessary laboratory testing.

Rita McCrackenRita K. McCracken, MD PhD CCFP (COE), FCFP.
Dr. McCracken is a full service family physician in East Vancouver and an Assistant Professor in the Department of Family Practice at the University of British Columbia. Her areas of study include interventions to improve prescribing in primary care and health human resource planning.

Aaron M Tejani, BSc (Pharm), PharmD.
Dr. Aaron M Tejani, is a researcher/educator with the Therapeutics Initiative (co-chair of the Education Working Group, member of the Drug Assessment Working Group), clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia), and Medication use evaluation pharmacist with Lower Mainland Pharmacy Services (Vancouver, BC). He completed his BSc(Pharm) at UBC (Vancouver) and Doctor of Pharmacy degree at Creighton University (Omaha, Nebraska).

Wade Thompson, PharmD, MSc, PhD.
Wade is a pharmacist and researcher working to ensure older persons are taking medications that are necessary, effective, safe, and consistent with their healthcare goals and treatment preferences. This primarily involves developing and evaluating strategies to stop medications when they are no longer a good fit (“deprescribing”). He is also an investigator with the initiative. Wade has worked clinically as a pharmacist in long-term care, geriatric outpatient clinics, and primary care clinics.

“If you have not attended a Therapeutics Initiative program before, it will change the way you think about the medication you prescribe. You will think more critically about evidence regarding harms and benefits.” – Past Participant

No Comments

Post A Comment